Financial constraints have seen IPO Lisbon (the country’s leading cancer hospital) admit that vital tests are not being done for patients ‘in time’.
Tabloid Correio da Manhã has already highlighted one death in the Algarve due to delays while almost 30 patients in the region are said to be waiting for green-lights that take far too long to come through.
Say reports, the issues stem from IPO Lisbon requiring “guarantees” that health entities will finance the tests.
CM concludes its report today with the question: “So how much does it cost to save a life?”
The test in question “has a value of around €200”, says the paper.